Kobayashi G S
Washington University School of Medicine, Department of Internal Medicine, St. Louis, MO 63110, USA.
Arch Med Res. 1995 Autumn;26(3):293-6.
The laboratory diagnoses or confirmation of fungal diseases are extremely important considerations in the proper and efficient management of patients experiencing these infections. When an infectious process is suspected, suitable material must be collected and submitted to the pathologist for microscopic examination and to the diagnostic laboratory for culture. The practice of modern medicine dictates that the turn-around time be reduced to a minimum so that specific therapy can be rapidly instituted. Unfortunately, the classical procedures used in processing specimens for isolation and identification of fungi implicated in these diseases are technically time consuming and on occasion labor-intensive. More importantly, fungi are slow growing and cultures are frequently held for 3 to 4 weeks before they are discarded as negative. With the exception of coccidioidomycosis, most attempts to develop serological tests for rapid diagnosis of fungal infections have been hampered by poor specificity caused by immunologic cross reactivity. To some extent, such problems can be circumvented by application of molecular biological techniques to these problems. For example, procedures have been developed that allow efficient screening of DNA expression libraries to identify useful recombinant antigens and production of selected antigens in quantity. This is potentially a practical approach using molecular biological techniques for development of sensitive, specific and practical reagents useful in the serological diagnosis of fungal infections. In addition, nucleic acid hybridization techniques based on the ability of complementary nucleic acid strands to specifically align and associate to form stable double-stranded complexes have been put to use to develop confirmation tests for a variety of important fungal isolates.(ABSTRACT TRUNCATED AT 250 WORDS)
在对患有这些真菌感染的患者进行恰当且有效的治疗过程中,实验室对真菌疾病的诊断或确认是极其重要的考量因素。当怀疑有感染过程时,必须采集合适的样本并提交给病理学家进行显微镜检查,同时提交给诊断实验室进行培养。现代医学实践要求将周转时间减至最短,以便能迅速开始特定治疗。不幸的是,用于处理样本以分离和鉴定这些疾病中涉及的真菌的传统方法在技术上耗时较长,有时还 labor-intensive(劳动密集型,此处可意译为“耗费人力”)。更重要的是,真菌生长缓慢,培养物通常要保存3至4周后才作为阴性结果被丢弃。除球孢子菌病外,大多数开发用于真菌感染快速诊断的血清学检测的尝试都因免疫交叉反应导致的特异性差而受阻。在一定程度上,通过将分子生物学技术应用于这些问题可以规避此类问题。例如,已开发出一些程序,可高效筛选DNA表达文库以鉴定有用的重组抗原,并大量生产选定的抗原。这可能是一种利用分子生物学技术开发用于真菌感染血清学诊断的灵敏、特异且实用试剂的切实可行方法。此外,基于互补核酸链特异性排列并缔合形成稳定双链复合物能力的核酸杂交技术已被用于开发针对多种重要真菌分离株的确认检测。(摘要截选至250字)